IgA nephropathy associated with a novel N-terminal mutation in factor H

European Journal of Pediatrics

Volumn 170, Issue 1, 2011, Pages 107-110

  Schmitt, Roland ^a   Krmar, Rafael T ^b   Kristoffersson, Anncharlotte ^a   Söderberg, Magnus ^b,c   Karpman, Diana ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Child; Complement; Factor H; IgA nephropathy

Indexed keywords

ALANINE; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; SERINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADOLESCENT; ARTICLE; BLOOD EXAMINATION; CASE REPORT; DISEASE PREDISPOSITION; EXON; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GLOMERULONEPHRITIS; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; MALIGNANT HYPERTENSION; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEINURIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; WEIGHT GAIN;

ADOLESCENT; COMPLEMENT FACTOR H; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION, MALIGNANT; MUTATION; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 79151483254     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-010-1279-3     Document Type: Article

References (27)

1. MC Bene GC Faure 1987 Composition of mesangial deposits in IgA nephropathy: complement factors Nephron 46 219 1:STN:280:DyaL2s3lvVGhsA%3D%3D 10.1159/000184350 3600937
2. K Benz K Amann 2010 Thrombotic microangiopathy: new insights Curr Opin Nephrol Hypertens 19 242 247 10.1097/MNH.0b013e3283378f25 20186056
3. J Caprioli F Castelletti S Bucchioni, et al. 2003 Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease Hum Mol Genet 12 3385 3395 1:CAS:528:DC%2BD3sXpsl2mtbw%3D 10.1093/hmg/ddg363 14583443 (Pubitemid 37541083)
4. A Chang J Kowalewska KD Smith, et al. 2006 A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy Clin Nephrol 66 397 404 1:STN:280:DC%2BD28jjvFSnsw%3D%3D 17176910
5. SR de Cordoba EG de Jorge 2008 Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H Clin Exp Immunol 151 1 13 10.1111/j.1365-2249.2007.03552.x 18081690 (Pubitemid 350230999)
6. M Edey L Strain R Ward, et al. 2009 Is complement factor H a susceptibility factor for IgA nephropathy? Mol Immunol 46 1405 1408 1:CAS:528:DC%2BD1MXjsVertrs%3D 10.1016/j.molimm.2008.12.002 19162324
7. M Endo H Ohi A Satomura 2001 Regulation of in situ complement activation via the lectin pathway in patients with IgA nephropathy Clin Nephrol 55 185 191 1:CAS:528:DC%2BD3MXpt1Khu7w%3D 11316237
8. M Espinosa R Ortega JM Gomez-Carrasco, et al. 2009 Mesangial C4d deposition: a new prognostic factor in IgA nephropathy Nephrol Dial Transplant 24 886 891 1:CAS:528:DC%2BD1MXisVSls78%3D 10.1093/ndt/gfn563 18842673
9. HE Gerritsen PL Turecek HP Schwarz, et al. 1999 Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP) Thromb Haemost 82 1386 1389 1:CAS:528:DyaK1MXnsVentbY%3D 10595623
10. K Giannakakis S Feriozzi M Perez, et al. 2007 Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy J Am Soc Nephrol 18 3139 3146 1:CAS:528:DC%2BD2sXhsVGgu73E 10.1681/ASN.2007030259 17978312 (Pubitemid 350223973)
11. PS Hiemstra A Gorter ME Stuurman, et al. 1987 Activation of the alternative pathway of complement by human serum IgA Eur J Immunol 17 321 326 1:CAS:528:DyaL2sXktVGnur8%3D 10.1002/eji.1830170304 3569402 (Pubitemid 17060784)
12. S Kuhn PF Zipfel 1996 Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H Eur J Immunol 26 2383 2387 1:STN:280:DyaK2s%2FlsVKmsA%3D%3D 10.1002/eji.1830261017 8898949 (Pubitemid 26340939)
13. R Miyazaki M Kuroda T Akiyama, et al. 1984 Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy Clin Nephrol 21 335 340 1:STN:280:DyaL2c3otlGltQ%3D%3D 6205804
14. S Morita T Sakai N Okamoto, et al. 1999 Hemolytic uremic syndrome associated with immunoglobulin A nephropathy: a case report and review of cases of hemolytic uremic syndrome with glomerular disease Intern Med 38 495 499 1:STN:280:DyaK1MzjslWlsQ%3D%3D 10.2169/internalmedicine.38.495 10411356
15. EW Rauterberg HM Lieberknecht AM Wingen E Ritz 1987 Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis Kidney Int 31 820 829 1:STN:280:DyaL2s7pvFKqsQ%3D%3D 10.1038/ki.1987.72 3573542
16. A Roos LH Bouwman DJ van Gijlswijk-Janssen, et al. 2001 Human IgA activates the complement system via the mannan-binding lectin pathway J Immunol 167 2861 2868 1:CAS:528:DC%2BD3MXmtlSjur4%3D 11509633
17. A Roos MP Rastaldi N Calvaresi, et al. 2006 Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease J Am Soc Nephrol 17 1724 1734 1:CAS:528:DC%2BD28XlvVemu7k%3D 10.1681/ASN.2005090923 16687629 (Pubitemid 43794676)
18. P Ruggenenti G Remuzzi 1996 Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomy Am J Kidney Dis 27 459 475 1:STN:280:DyaK283nt1ejug%3D%3D 10.1016/S0272-6386(96)90155-9 8678055
19. JM Saland P Ruggenenti P Remuzzi, et al. 2009 Liver-kidney transplantation to cure atypical hemolytic uremic syndrome J Am Soc Nephrol 20 940 949 1:CAS:528:DC%2BD1MXlvFKqsbg%3D 10.1681/ASN.2008080906 19092117
20. M Stangou E Alexopoulos A Pantzaki, et al. 2008 C5b-9 glomerular deposition and tubular alpha(3)beta(1)-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy Scand J Urol Nephrol 42 1 8 10.1080/ 00365590801943241
21. Y Tomino H Sakai Y Nomoto, et al. 1981 Deposition of C4-binding protein and beta 1H globulin in kidneys of patients with IgA nephropathy Tokai J Exp Clin Med 6 217 222 1:STN:280:DyaL38%2Fmt1KmsQ%3D%3D 6458121
22. F Vaziri-Sani L Holmberg AG Sjöholm, et al. 2006 Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome Kidney Int 69 981 988 1:CAS:528:DC%2BD28XitFGht7c%3D 10.1038/sj.ki.5000155 16528247 (Pubitemid 43372172)
23. S Watanabe Y Yamaguchi T Suzuki, et al. 2001 Inherited factor H dysfunction and complement-associated glomerulonephritis in renal grafts of first and second transplantations Clin Transplant 15 Suppl 5 45 50 10.1034/j.1399-0012.2001.0150s5045.x 11791795 (Pubitemid 34013561)
24. RJ Wyatt BA Julian ML Rivas 1991 Role for specific complement phenotypes and deficiencies in the clinical expression of IgA nephropathy Am J Med Sci 301 115 123 1:STN:280:DyaK3M7ovFajtQ%3D%3D 10.1097/00000441-199102000-00006 1826409
25. RJ Wyatt BA Julian A Weinstein, et al. 1982 Partial H (beta 1H) deficiency and glomerulonephritis in two families J Clin Immunol 2 110 117 1:STN:280:DyaL387msl2nsQ%3D%3D 10.1007/BF00916894 6461667
26. JJ Zhang L Jiang G Liu, et al. 2009 Levels of urinary complement factor H in patients with IgA nephropathy are closely associated with disease activity Scand J Immunol 69 457 464 1:CAS:528:DC%2BD1MXlvVanu70%3D 10.1111/j.1365-3083. 2009.02234.x 19508377
27. PF Zipfel S Heinen M Jozsi C Skerka 2006 Complement and diseases: defective alternative pathway control results in kidney and eye diseases Mol Immunol 43 97 106 1:CAS:528:DC%2BD2MXms1Ogu7Y%3D 10.1016/j.molimm.2005.06.015 16026839 (Pubitemid 41021526)